Treatment of the Hutchinson-Gilford Progeria Syndrome With a Combination of Pravastatin and Zoledronic Acid
Condition(s):Hutchinson-Gilford Progeria SyndromeLast Updated:July 8, 2013Completed
Hide Studies Not Open or Pending
Condition(s):Hutchinson-Gilford Progeria SyndromeLast Updated:July 8, 2013Completed
Condition(s):ProgeriaLast Updated:February 27, 2023Active, not recruiting
Condition(s):Hutchinson-Gilford Progeria SyndromeLast Updated:November 4, 2020Completed
Condition(s):Progeria; Hutchinson-Gilford SyndromeLast Updated:June 13, 2019Completed
Condition(s):ProgeriaLast Updated:February 27, 2023Enrolling by invitation
Condition(s):Progeria; HGPSLast Updated:April 15, 2021Approved for marketing
Condition(s):ProgeriaLast Updated:November 15, 2019Completed
Condition(s):Progeria; Hutchinson-Gilford SyndromeLast Updated:June 25, 2019Completed
Condition(s):Hutchinson-Gilford Progeria Syndrome; Werner SyndromeLast Updated:September 22, 2021Completed
Condition(s):HIV Infection; Aging Accelerated; Antiretroviral TherapiesLast Updated:December 27, 2012Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.